#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Lymphoma Neuroblastoma Primary mediastinal large B-cell lymphoma Bronchopulmonary dysplasia Noonan syndrome Mucopolysaccharidosis III Thalassaemia alpha Congenital absence of bile ducts Mucopolysaccharidosis I Kawasaki's disease Extra-osseous Ewing's sarcoma metastatic Pulmonary fibrosis Laryngeal squamous cell carcinoma Pseudoxanthoma elasticum Monogenic diabetes More trials…

    Learn about Rare Diseases

    Marginal zone lymphoma refractory – Basic Information Burkitt’s lymphoma – Diagnostics Brain stem glioma Anaplastic thyroid cancer – Trials in Disease Malignant fibrous histiocytoma – Life with Disease Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Basic Information Langerhans cell sarcoma – Life with Disease Lysosomal storage disorder – Life with Disease Angiosarcoma non-metastatic – Treatment Loeys-Dietz syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pancreas Powder Sirexatamab Fenofibrate Micronised CARBOMER 980 Histamine Dihydrochloride Isoprenaline Hydrochloride Cilastatin Ublituximab Olopatadine [18F]Mc225 Zipalertinib HALOBETASOL PROPIONATE Cd19-Car_Lenti_Allo Ly3437943 Sodium Timrepigene Emparvovec Trientine Dihydrochloride SALICYLIC ACID Vidofludimus Calcium Dried Ferrous Sulfate Lysine Acetate More therapies…

    Learn about Your Condition

    Perineal injury Colorectal adenoma Craniosynostosis Primary hypercholesterolaemia Pancreatic carcinoma stage IV Arrhythmia supraventricular Mitral valve prolapse Gastrointestinal disorder Nephrotic syndrome Aortic disorder Alagille syndrome Hand fracture Combined immunodeficiency Oesophageal cancer metastatic Vaginal haemorrhage More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Allogenic stem cell transplantation

  • Testing Stem Cell Transplant Methods and Medications Including Ruxolitinib and Blinatumomab for Children and Young Adults with Acute Lymphoblastic Leukemia

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Allogenic stem cell transplantation
    Investigated Drugs:
    • Treosulfan
    • Thiotepa
    • Busulfan
    Austria Belgium Czechia Denmark Finland France +6

  • A Study of Maribavir for Cytomegalovirus Infection in Stem Cell Transplant Patients Who Cannot Take or Did Not Tolerate Standard Treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Allogenic stem cell transplantation
    • Cytomegalovirus infection
    Investigated Drugs:
    • Maribavir
    Italy

  • Study on RSV Vaccination with Abrysvo and Arexvy for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Allogenic stem cell transplantation
    Investigated Drugs:
    • Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
    Belgium

  • Study on Fecal Microbiota Transplantation to Prevent Complications in Patients After Stem Cell Transplant for Blood Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Allogenic stem cell transplantation
    • Haematological malignancy
    Investigated Drugs:
    • Allogeneic Faecal Microbiota
    France

  • Study on Ivosidenib for Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome with IDH1 Mutation After Stem Cell Transplant

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome
    • Allogenic stem cell transplantation
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Ivosidenib
    Germany

  • Study of iG-Tregs for Preventing Graft-versus-Host Disease in Adults Undergoing HLA-Matched Sibling Stem Cell Transplantation

    Recruiting

    1 1 1
    Investigated Diseases:
    • Allogenic stem cell transplantation
    Investigated Drugs:
    • IG-TREGS
    Greece
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!